tailieunhanh - báo cáo hóa học:" The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL)"

Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí hóa học đề tài : The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL) | Health and Quality of Life Outcomes BioMed Central Research The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire UFS-QOL Gale Harding X1 Karin S Coynef1 Christine LThompson 1 and James B Spiest2 Open Access Address 1United BioSource Corporation 7101 Wisconsin Ave Suite 600 Bethesda MD 20814 USA and 2Georgetown University Dept. of Radiology Room CG201 Bldg. CC 3800 Reservoir Rd NW Washington DC 20007-2197 USA Email Gale Harding - Karin S Coyne - Christine LThompson - James B Spies - spiesj@ Corresponding author fEqual contributors Published 12 November 2008 Received 17 September 2007 Health and Quality of Life Outcomes 2008 6 99 doi 1477-7525-6-99 Accepted 12 November 2008 This article is available from http content 6 1 99 2008 Harding et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background A number of noninvasive alternatives to hysterectomy have become available as treatments for uterine fibroids. These alternative therapies however may not relieve all symptoms. Consequently the need for patient-reported outcomes to assess symptom reduction of uterine fibroids has become increasingly important to evaluate the clinical success of patients who choose these alternative therapies. The purpose of the study was to examine the responsiveness of the Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire UFS-QOL with treatment of uterine fibroids. Methods The responsiveness of the UFS-QOL was assessed as a post-hoc analysis of patients treated with MRI-guided focused ultrasound thermal ablation MRgFUS for uterine .